Pharma in Focus - knowledge in power
20 - 26 Feb 2012
 
Market Review: Who's winning in the antihypertensive market?
Competition among antihypertensive drugs in the Australian market is robust as older options, especially ramipril, feel the heat from new fixed dose combinations that are showing rapid growth
Action in generic space shows how market is changing
This week we've taken another look at the forthcoming PBS listings for March and it shows how much the Australian pharma market is set to change this year
Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 8,500 readers every working day
  • Great reaction with click through rates of up to 6.5%
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

BACK

 
Welcome Guest
Instant Update: Thurs 23 February
..full report
Pfizer generics plan bears PBS fruit
..full report
Apotex attacks Roche's Valcyte
..full report
PBS growth in long-term decline
..full report
Leflunomide judgement appealed
..full report
Biosimilars pact proving elusive
..full report
Continuous dispensing passes Reps
..full report
Aust safe from methotrexate shorts
..full report
Spider venom painkiller attracts J&J
..full report
Latest ARTG registrations
..full report

© 2007 Lush Media | Privacy Statement | Subscribe to Pharma in Focus